How Eliquis Patient Assistance Programs Work at Bristol Myers Squibb
For many people managing atrial fibrillation or other conditions requiring blood thinners, the cost of prescription medication can be a significant burden. Bristol Myers Squibb, the manufacturer of Eliquis, offers patient assistance programs designed to help eligible individuals access the medication they need. Understanding how these programs work can make a real difference in managing long-term treatment costs.
Medications like Eliquis (apixaban) are widely prescribed for conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. While the drug is clinically effective, its retail price can place it out of reach for patients without adequate insurance coverage or financial resources. Bristol Myers Squibb, in partnership with Pfizer, has developed support structures specifically aimed at reducing financial barriers for qualifying patients.
This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.
What is Eliquis Patient Assistance?
The Eliquis patient assistance program is a manufacturer-sponsored initiative that provides free or reduced-cost medication to patients who meet specific eligibility requirements. Administered through the Bristol Myers Squibb Patient Assistance Foundation and the BMS Access Support program, it is designed to serve uninsured or underinsured patients in the United States who cannot afford their prescribed medication. The program operates separately from insurance and is not a substitute for coverage, but rather a supplemental resource for those who genuinely cannot manage out-of-pocket costs.
Who May Qualify for Assistance
Eligibility for the Eliquis patient assistance program is typically based on several factors. Applicants generally need to be residents of the United States, have a valid prescription from a licensed healthcare provider, and demonstrate financial need based on household income and size. Patients who are uninsured or who have insurance that does not cover Eliquis may also be considered. Those already enrolled in government programs such as Medicaid may not qualify, as eligibility rules are structured to avoid duplication of benefits. Income thresholds are reviewed periodically and may change, so verifying current requirements directly through the program is always advisable.
How to Apply: Required Documents and Step-by-Step Process
Applying for the Eliquis patient assistance program involves several steps. First, patients or their healthcare providers can initiate the process by visiting the official BMS Access Support website or calling the program’s dedicated helpline. The application typically requires proof of income, such as recent tax returns or pay stubs, a completed and signed application form, and a valid prescription or letter from the treating physician. Some applications can be submitted directly by the healthcare provider on behalf of the patient, which can streamline the process. Once submitted, applications are reviewed, and patients are usually notified about their status within a few weeks. Approved patients typically receive medication directly by mail.
What Assistance Typically Covers and Program Limitations
For approved applicants, the program generally provides Eliquis at no cost or at a significantly reduced price for a defined period, often on a renewable basis depending on continued eligibility. The assistance is usually limited to the specific medication and does not extend to other treatments, lab tests, or associated medical visits. There are also limitations around eligibility renewal, as patients must reapply periodically and demonstrate continued financial need. It is important to note that program terms, income limits, and coverage scope are subject to change. Patients should also be aware that acceptance into the program is not guaranteed and is subject to available resources.
| Assistance Type | Program Name | Provider | What It Covers | Estimated Cost to Patient |
|---|---|---|---|---|
| Free Medication | BMS Patient Assistance Foundation | Bristol Myers Squibb | Full supply of Eliquis for qualifying uninsured patients | Free (income-based) |
| Co-pay Support | Eliquis 360 Support Co-pay Card | Bristol Myers Squibb / Pfizer | Reduces co-pay for commercially insured patients | Varies; may reduce cost significantly |
| Mail-order Assistance | Prescription Delivery via Foundation | Bristol Myers Squibb | Medication mailed directly to patient | Free or reduced (if approved) |
| Healthcare Provider Support | BMS Access Support Hub | Bristol Myers Squibb | Provider-initiated applications and reimbursement guidance | N/A |
Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.
Navigating medication costs is a challenge that affects patients across many countries and income levels. Patient assistance programs offered by pharmaceutical manufacturers like Bristol Myers Squibb provide a structured pathway for eligible individuals to access critical medications without prohibitive financial strain. Understanding eligibility requirements, the application process, and what the program covers helps patients and caregivers make informed decisions about pursuing this type of support.
